Abstract:Background: Gram-negative bacilli are one of the most common causes of various infections in clinical. The emergence and global spread of multi-drug resistant gram-negative bacilli has become a major challenge in the global public health field. Methods: A total of 51,189 non-repetitive strains of gram-negative bacilli were isolated in clinical settings. The antimicrobial susceptibility testing was conducted by using the automated VITEK 2 compact system and the matched AST susceptibility test card, complemented by the disk diffusion method. The antimicrobial susceptibility results were interpreted by CLSI. Rates of MDR and XDR in Klebsiella pneumoniae , Acinetobacter baumannii , and Pseudomonas aeruginosa were investigated. Used the chi-square test to determine whether the antimicrobial resistance rates of four major gram-negative bacilli isolated from ICU and non-ICU department have statistical differences. Results: Escherichia coli (31.4%), Klebsiella spp. (21.2%), Acinetobacter spp. (13.8%), and P. aeruginosa (11.0%) were the most frequently isolated gram-negative bacilli. Escherichia coli was the top one organism isolated from urinary tract (68.4%), bloodstream (39.9%), body fluid (33.2%), wound and pus (37%), except for respiratory tract (8.8%). Whereas Acinetobacter baumannii and K. pneumoniae were the major isolated organisms from respiratory tract. Acinetobacter baumannii showed high resistance to fluoroquinolones, β-lactam/β-lactamase inhibitor combinations class, ceftazidime, cefepime, imipenem, and meropenem, the resistance rates reached more than 70%. Ceftazidime showed a lower resistance rate to E. coli than ceftriaxone. For E. coli , fluoroquinolones showed a high resistance rate (ciprofloxacin 61.36% and levofloxacin 53.97%), whereas amikacin, carbapenems exhibited a lower resistance rate fluctuating at 2%. Acinetobacter baumannii and K. pneumoniae showed rapid increases in carbapenem resistance whereas E. coli had the lowest resistance rate and remain stable at 2%. Acinetobacter baumannii exhibited the highest rate of MDR and XDR, reaching 60–80 and 45–55%, respectively. Compared to non-ICU departments, the resistance rates of four major gram-negative bacilli in the ICU department were much higher and the differences were statistically significant ( p < 0.05). Conclusion: Amikacin, carbapenems, and piperacillin/tazobactam exhibited relatively high sensitivity, whereas fluoroquinolones showed high resistance rate whether they can be the first-line antimicrobials for empirical treatment of UTI should take more consideration. The gram-negative bacilli in ICU were more resistance than that in non-ICU. These findings are helpful for clinicians using antimicrobials reasonably.

Antimicrobial resistance of Acinetobacter baumanii in ICU

Sample cluster analysis of resistance genes in multidrug-resistant Acinetobacter baumannii

Drug resistance of Acinetobacter baumannii during 2009-2011

Drug resistance of Acinetobacter baumanniiin ICU and general wards: a comparative study

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Surveillance of antimicrobial resistance among clinical isolates from intensive care units in tertiary hospital, 2012

Analysis of Drug Resistance of Acinetobacter Baumanii in Patients with Ventilator-Associated Pneumonia in Intensive Care Unit

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

Antimicrobial Susceptibility of Multi-drug Resistant Acinetobacter Baumannii and Pseudomonas Aeruginosa Isolates from 27 Hospitals in China

Survey on multi-resistant Acinetobacter baumannii infection and analysis of drug susceptibility

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Ministry of Health National Antimicrobial Resistance Investigation Net Annual Report of 2011: Surveillance of Antimicrobial Resistance in Bacteria from Intensive Care Units

Antibiotic Resistance of Acinetobacter baumannii in ICU

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Resistance Trends Among 1,294 Nosocomial Acinetobacter baumannii Strains from a Tertiary General Hospital in China, 2014 - 2017.

Nosocomial Infections with Acinetobacter Baumannii : Clinical Distribution and Drug Resistance

Multidrug Resistance of Acinetobacter baumanii and Homogeneous Analysis

265 strains of multiple drug resistance of Acinetobacter baumannii clinical distribution and drug resistance analysis

Distribution and antimicrobial resistance analysis of gram-negative bacilli isolated from a tertiary hospital in Central China: a 10-year retrospective study from 2012 to 2021

Drug Resistance Investigation of Lower Respiratory Tract Infection with Gram-negative Bacilli in ICU

Monitoring and Control of Pan-Drug Resistant Acinetobacter Baumannii Colonization and Infection in a Medical Intensive Care Unit